In studies conducted for breast cancer, it has been stated that the SEC61G gene can be used as a diagnostic biomarker and therapeutic target, since high expression of SEC61G is associated with the expression of the proliferation marker Ki-67 and glycolysis. The gene discussed is SEC61G; the disease is breast cancer.